Fundraising FoxAinos
NASDAQ: AIMDSan Diego, US · Texas corporation
Find your way into Ainos
Sign up to see every warm intro you have to Ainos
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Ainos team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Ainos is a medtech company operating three business divisions: pharmaceuticals focused on low-dose interferon therapies, medical devices including AI-powered point-of-care diagnostics, and preventive medicine applications of mRNA technology. The company serves healthcare providers and patients across infectious disease, female health, and oncology treatment areas.
Founders & leadership
CT
Chun-Hsien TsaiExecutive
HL
Hsin-Liang LeeChief Financial Officer
Reported raises · per SEC filings
Form D private placements$21.8M disclosed across 5 of 7 rounds · 2015–2024
▶$20MraisedMay 2021 · BiotechnologyRule 506(b)
▶$20MraisedMay 2021 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Chun-Hsien TsaiDirector, Executive Officer, Executive Officer
- Offering amount
- $20M
- Amount sold
- $20M
- First sale
- Apr 2021
- Incorporated
- Corporation, Texas
- Federal exemptions
- 06b
▶$721KraisedAug 2018 · 10 investors · BiotechnologyRule 506(b)
▶$721KraisedAug 2018 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- EDWARD L MORRISDirector
- DANIEL FISHERDirector
- NICHOLAS MORENDirector
- YASUSHI CHIKAGAMIDirector
- BERNARD COHENExecutive Officer
- STEPHEN CHENExecutive Officer, Director
- Offering amount
- $30M
- Amount sold
- $721K
- Minimum investment
- $37.5K
- Finders' fees
- $72.1K
- Proceeds to insiders
- $200K
- Placement agents
- STEVEN HONG, DAVID SHAO WEI FANG, ROSALYN HUI JIN, TIMOTHY LIU, KELVIN HU, KAI-YUAN CHENG, YAN-YING LIU, UHO WELLNESS CORPORATION
- First sale
- Dec 2017
- Incorporated
- Corporation, Texas
- Federal exemptions
- 06b
▶$476.5KraisedOct 2017 · 4 investors · BiotechnologyRule 506(b)
▶$476.5KraisedOct 2017 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- DANIEL FISHERDirector
- BERNARD COHENExecutive Officer
- STEPHEN CHENExecutive Officer, Director
- NICHOLAS MORENDirector
- YASUSHI CHIKAGAMIDirector
- PAUL TIBBITSDirector
- Offering amount
- $2.8M
- Amount sold
- $476.5K
- Minimum investment
- $28.1K
- First sale
- Apr 2016
- Incorporated
- Corporation, Texas
- Federal exemptions
- 06b
▶$600KraisedApr 2016 · 1 investors · BiotechnologyRule 506(b)
▶$600KraisedApr 2016 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- STEPHEN CHENExecutive Officer, Director
- PAUL TIBBITSDirector
- DANIEL FISHERDirector
- BERNARD COHENExecutive Officer
- YASUSHI CHIKAGAMIDirector
- NICHOLAS MORENDirector
- Offering amount
- $1M
- Amount sold
- $600K
- Minimum investment
- $25K
- Proceeds to insiders
- $75K
- First sale
- Mar 2016
- Incorporated
- Corporation, Texas
- Federal exemptions
- 06b
▶$37.5KraisedAug 2015 · 1 investors · Biotechnology
▶$37.5KraisedAug 2015 · 1 investors · Biotechnology
Officers, directors & promoters on the filing
- PAUL TIBBITSDirector
- NICHOLAS C MORENDirector
- STEPHEN T CHENExecutive Officer, Director
- BERNARD COHENExecutive Officer
- YASUSHI CHIKAGAMIDirector
- DANIEL FISHERDirector
- Amount sold
- $37.5K
- Minimum investment
- $5K
- Proceeds to insiders
- $80K
- First sale
- Jul 2015
- Incorporated
- Corporation, Texas
- Federal exemptions
- 05
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Valuation · disclosed
Disclosed events$40.9Mvaluation at IPOAug 2022 · $4.25/share · 424B4
filing ↗Source: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.
Related companies · 3
AirsenseAIRSENSE manufactures chemical detection devices for defense operations that identify chemical warfare agents, toxic industrial chemicals, and explosives in real time. The company serves military and defense personnel requiring rapid threat detection in field operations.
AryballeAryballe operates an ISO 7 cleanroom manufacturing facility for sensor production, enabling chemical functionalization and testing at scale with up to 1 million sensors per year capacity. The in-house production line supports wafer-level processing on 8-inch substrates with integrated process optimization and industrial production.
Voler SystemsVoler Systems publishes a podcast featuring conversations with industry leaders about engineering innovation, product development, and technologies for next-generation devices.
Companies working in the same space as Ainos.
Frequently asked questions
- What does Ainos do?
- Ainos is a medtech company operating three business divisions: pharmaceuticals focused on low-dose interferon therapies, medical devices including AI-powered point-of-care diagnostics, and preventive medicine applications of mRNA technology. The company serves healthcare providers and patients across infectious disease, female health, and oncology treatment areas.
- How much funding has Ainos raised?
- Ainos has disclosed $21.8M raised across 5 of its 7 known rounds.
- Where is Ainos headquartered?
- Ainos is headquartered in San Diego, US.